Finally, while magnesium may theoretically improve insulin sensitivity and glucose metabolism, there is insufficient evidence to suggest that supplementation significantly alters the glycemic efficacy of GLP-1 drugs
It can be, if its done with fat transfer
Phase 3 TRIUMPH-4 (NCT05931367) reported 28.7% body weight loss at 12 mg, 26.4% at 9 mg, vs 2.1% placebo at 68 weeks
This omission limits pharmacological context, hinders potency normalization across studies, and constrains the prioritization of peptide leads for translational development [177, 178]
A large observational study published in mid-2025 reported that diabetic patients using GLP-1 drugs experienced a two- to threefold increased risk of developing nAMD compared to non-users
If you have any issues, theyll adjust the plan